Huntington's disease and HDACi: would sulpiride and valproate be of therapeutic value?

Med Hypotheses. 2007;69(4):964-5. doi: 10.1016/j.mehy.2007.02.025. Epub 2007 Apr 10.

Authors

L Tremolizzo, V Rodriguez-Menendez, J C DiFrancesco, G Sala, A Galbussera, I Appollonio, C Ferrarese

PMID: 17428619
DOI: 10.1016/j.mehy.2007.02.025

No abstract available

Publication types

Letter

MeSH terms

Anticonvulsants / therapeutic use
Antipsychotic Agents / therapeutic use
Histone Deacetylases / drug effects
Histone Deacetylases / metabolism*
Humans
Huntington Disease / drug therapy*
Huntington Disease / enzymology
Huntington Disease / physiopathology*
Motor Activity / drug effects
Sulpiride / therapeutic use*
Valproic Acid / therapeutic use*

Substances

Anticonvulsants
Antipsychotic Agents
Valproic Acid
Sulpiride
Histone Deacetylases